SHIP1 REGULATION OF DAP12 IN OSTEOCLAST DEVELOPMENT AND FUNCTION

SHIP1 对 DAP12 对破骨细胞发育和功能的调节

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Osteoclasts are inappropriately activated in autoimmune disease states such as rheumatoid arthritis. While signals through RANKL and MCSF are required for osteoclast differentiation, regulation by other receptors is less well defined. We have focused on TREM2, an immune receptor found in osteoclasts. TREM2 associates with DAP12, an ITAM (immunoreceptor tyrosine-based activation motif) containing signaling adapter protein. TREM2/DAP12 signaling is required for osteoclast maturation and activates osteoclast fusion and migration in vitro. Intracellular phosphatases negatively regulate many ITAM adapter proteins in hematopoietic cells. As such, we investigated the role of phosphatases inhibiting TREM2/DAP12 signals in osteoclasts. Our data shows that SH2 domain-containing 5' inositol phosphatase (SHIP1) and DAP12 are associated in osteoclast cell lysates. SHIP1 null preosteoclasts are hyper-responsive to TREM2/DAP12 signaling during osteoclastogenesis indicating that SHIP1 has a functional role in inhibiting this pathway. These data suggest that SHIP1 phosphatase regulates DAP12 signaling in osteoclasts. Using in vitro osteoclastogenesis assays from primary murine osteoclast cultures from C57Bl6 and SHIP1-/- mice we are determining the role of SHIP1 in regulating DAP12 signals. We are mapping the protein-protein interactions between DAP12 and SHIP1. We are determining whether SHIP1 regulates DAP12 activation in response to other stimuli including M-CSF and osteopontin. These studies will reveal the functional nature of SHIP1 regulation of DAP12 signaling as well as the important protein domains required for this regulation in osteoclasts and might lead to novel strategies to inhibit osteoclast differentiation or activation.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 破骨细胞在自身免疫性疾病状态如类风湿性关节炎中被不适当地激活。虽然通过RANKL和MCSF的信号是破骨细胞分化所必需的,但其他受体的调节作用尚不明确。 我们专注于TREM 2,一种在破骨细胞中发现的免疫受体。TREM 2与DAP 12结合,DAP 12是一种含有信号转导衔接蛋白的ITAM(基于免疫受体酪氨酸的激活基序)。 TREM 2/DAP 12信号传导是破骨细胞成熟所需的,并在体外激活破骨细胞融合和迁移。 细胞内磷酸酶负调节造血细胞中的许多ITAM衔接蛋白。因此,我们研究了磷酸酶抑制破骨细胞中TREM 2/DAP 12信号的作用。我们的数据表明,含SH 2结构域的5'肌醇磷酸酶(SHIP 1)和DAP 12在破骨细胞裂解物中相关。SHIP 1无效的前破骨细胞在破骨细胞生成期间对TREM 2/DAP 12信号传导具有高响应性,表明SHIP 1在抑制该途径中具有功能性作用。这些数据表明,SHIP 1磷酸酶调节破骨细胞中的DAP 12信号传导。 使用来自C57 B16和SHIP 1-/-小鼠的原代小鼠破骨细胞培养物的体外破骨细胞生成试验,我们正在确定SHIP 1在调节DAP 12信号中的作用。我们正在绘制DAP 12和SHIP 1之间的蛋白质-蛋白质相互作用。我们正在确定SHIP 1是否调节DAP 12的激活,以响应其他刺激,包括M-CSF和骨桥蛋白。这些研究将揭示SHIP 1调节DAP 12信号传导的功能性质以及破骨细胞中这种调节所需的重要蛋白质结构域,并可能导致抑制破骨细胞分化或活化的新策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary Beth Humphrey其他文献

735 - Vagal Nerve Stimulation Mitigates Pain in Mouse Models of Post-Traumatic Osteoarthritis
  • DOI:
    10.1016/j.joca.2024.02.750
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Mary Beth Humphrey;Shivmurat Yadav;Monika Niewiadomska;Lynsie Morris;Taylor Connor;Jessica Lumry;Sanique South;Emmaline Prinz;Stavros Stavrakis;Matlock Jeffries;Timothy Griffin
  • 通讯作者:
    Timothy Griffin
Exercise induces dynamic changes in intra-articular metabolism and inflammation associated with remodeling of the infrapatellar fat pad in mice
运动可引起小鼠髌下脂肪垫重塑相关的关节内代谢和炎症的动态变化
  • DOI:
    10.1038/s41598-025-86726-0
  • 发表时间:
    2025-01-18
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Timothy M. Griffin;Ravi K. Komaravolu;Erika Barboza Prado Lopes;Padmaja Mehta-D’souza;Taylor Conner;Tessa Kovats;Susan Kovats;Madeline Allen;Peyton Harris;Mary Beth Humphrey;Hope D. Welhaven;Priyanka Brahmachary;Ronald K. June
  • 通讯作者:
    Ronald K. June
Current Treatment for Glucocorticoid-Induced Osteoporosis: Beyond Bisphosphonates

Mary Beth Humphrey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary Beth Humphrey', 18)}}的其他基金

ShEEP Request for SCANCO microCT
SheEEP 请求 SCANCO microCT
  • 批准号:
    10738633
  • 财政年份:
    2023
  • 资助金额:
    $ 9.66万
  • 项目类别:
BCCMA: Targeting Osteoarthritis Pain and Progression: Preclinical OA models of vagal nerve stimulation to reduce pain and progression of OA
BCCMA:针对骨关节炎疼痛和进展:通过刺激迷走神经来减轻骨关节炎疼痛和进展的临床前 OA 模型
  • 批准号:
    10485419
  • 财政年份:
    2022
  • 资助金额:
    $ 9.66万
  • 项目类别:
Calcium Regulation in Osteoclasts
破骨细胞中的钙调节
  • 批准号:
    8737008
  • 财政年份:
    2013
  • 资助金额:
    $ 9.66万
  • 项目类别:
Calcium Regulation in Osteoclasts
破骨细胞中的钙调节
  • 批准号:
    8913682
  • 财政年份:
    2013
  • 资助金额:
    $ 9.66万
  • 项目类别:
Calcium Regulation in Osteoclasts
破骨细胞中的钙调节
  • 批准号:
    8628387
  • 财政年份:
    2013
  • 资助金额:
    $ 9.66万
  • 项目类别:
Calcium Regulation in Osteoclasts
破骨细胞中的钙调节
  • 批准号:
    9353297
  • 财政年份:
    2013
  • 资助金额:
    $ 9.66万
  • 项目类别:
UNDERSTANDING THE ROLE OF ALTERNATIVE SPLICING IN THE TNFAIP3 SLE-RISK ALLELES
了解选择性剪接在 TNFAIP3 SLE 风险等位基因中的作用
  • 批准号:
    8359795
  • 财政年份:
    2011
  • 资助金额:
    $ 9.66万
  • 项目类别:
UNDERSTANDING THE ROLE OF ALTERNATIVE SPLICING IN THE TNFAIP3 SLE-RISK ALLELES
了解选择性剪接在 TNFAIP3 SLE 风险等位基因中的作用
  • 批准号:
    8168263
  • 财政年份:
    2010
  • 资助金额:
    $ 9.66万
  • 项目类别:
Mechanism of ITAM Signal Regulation in Osteoclasts
破骨细胞ITAM信号调控机制
  • 批准号:
    8305426
  • 财政年份:
    2008
  • 资助金额:
    $ 9.66万
  • 项目类别:
Mechanism of ITAM Signal Regulation in Osteoclasts
破骨细胞ITAM信号调控机制
  • 批准号:
    7906881
  • 财政年份:
    2008
  • 资助金额:
    $ 9.66万
  • 项目类别:

相似海外基金

B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
  • 批准号:
    MR/Y033701/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.66万
  • 项目类别:
    Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 9.66万
  • 项目类别:
Applying advanced understanding of CTLA-4 function to optimise therapies for autoimmunity
应用对 CTLA-4 功能的深入理解来优化自身免疫疗法
  • 批准号:
    MR/Y001273/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.66万
  • 项目类别:
    Research Grant
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
MUC16 (CA125) 突变促进系统性硬化症的纤维化和自身免疫
  • 批准号:
    478933
  • 财政年份:
    2023
  • 资助金额:
    $ 9.66万
  • 项目类别:
    Operating Grants
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
新发自身免疫/纵向免疫系统分析(MONA-LISA)的机制
  • 批准号:
    10655219
  • 财政年份:
    2023
  • 资助金额:
    $ 9.66万
  • 项目类别:
Development of serologic test for early risk stratification of islet autoimmunity in genetically predisposed T1D individuals
开发用于遗传易感性 T1D 个体胰岛自身免疫早期风险分层的血清学检测
  • 批准号:
    10760885
  • 财政年份:
    2023
  • 资助金额:
    $ 9.66万
  • 项目类别:
Autoimmunity-Associated B Cells in Lupus Nephritis
狼疮性肾炎中自身免疫相关的 B 细胞
  • 批准号:
    10582053
  • 财政年份:
    2023
  • 资助金额:
    $ 9.66万
  • 项目类别:
Understanding autoimmunity: Why do B cells sometimes attack our tissues instead of protecting us from infections?
了解自身免疫:为什么 B 细胞有时会攻击我们的组织而不是保护我们免受感染?
  • 批准号:
    2889164
  • 财政年份:
    2023
  • 资助金额:
    $ 9.66万
  • 项目类别:
    Studentship
Heparan sulfate as a platform to boost regulatory T cell suppression of autoimmunity
硫酸乙酰肝素作为增强调节性 T 细胞抑制自身免疫的平台
  • 批准号:
    490663
  • 财政年份:
    2023
  • 资助金额:
    $ 9.66万
  • 项目类别:
    Operating Grants
The interplay of sex hormones and chromosomes dictates pathogenicity in progressive CNS autoimmunity.
性激素和染色体的相互作用决定了进行性中枢神经系统自身免疫的致病性。
  • 批准号:
    488982
  • 财政年份:
    2023
  • 资助金额:
    $ 9.66万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了